EHA 2017 | Immunotherapy and its dependence on T-cells

Name: Immunotherapy and its dependence on T-cells
Uploaded: 2017-06-22T00:00:00.000Z
Duration: 1 min 10 s
Description: Marion Subklewe, MD, from LMU-University Hospital, Munich, Germany, discusses the necessity to monitor T-cell count in patients who will be subject to immunotherapy and to make sure that patients do not receive any prior treatment that would affect their T-cell count (e.g. cytarabine). This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.

Marion Subklewe • 22 Jun 2017

EHA 2017

Acute Myeloid Leukemia

Marion Subklewe, MD, from LMU-University Hospital, Munich, Germany, discusses the necessity to monitor T-cell count in patients who will be subject to immunotherapy and to make sure that patients do not receive any prior treatment that would affect their T-cell count (e.g. cytarabine). This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.